Business Wire

09 Jun 2026, 00:34 UTC · 3h ago

Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer

Read original · https://www.businesswire.com/news/home/20260608963481/en/Zai-Lab-Receives-China-NMPA-Approval-of-TIVDAK%C2%AE-tisotumab-vedotin-for-injection-for-the-Treatment-of-Adult-Patients-with-Recurrent-or-Metastatic-Cervical-Cancer/

Search tags

Story key points

1 claims · impact-rated

What matters in this story

1
China's NMPA has approved the Biologics License Application for TIVDAK for the treatment of adult patients with recurrent or metastatic cervical cancer. — Regulatory approval opens a significant new commercial market in China for Zai Lab and its partner, creating a direct path to revenue growth.
+0.60

Ticker attribution

Model heads

Sentiment in this article

ZLAB+0.80
The company received NMPA approval for TIVDAK to treat cervical cancer, representing a significant regulatory win.

Relationships in this article

No ticker relationship head found.

Early access

You’re reading about it. Someone else is already positioned.

News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.

ZLAB

Browse live screenings

6 related stories

Zacks Investment Research
10h ago
Sanofi Wins EU Nod for Subcutaneous Sarclisa in Multiple Myeloma
- biotech
- drug approval
- oncology
Read

Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin fo… · News Impact Screener

Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Sanofi Wins EU Nod for Subcutaneous Sarclisa in Multiple Myeloma

Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Sanofi Wins EU Nod for Subcutaneous Sarclisa in Multiple Myeloma

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

Pentagon expands list of China military-linked firms to include Alibaba, Baidu in fresh blow to diplomatic thaw

NTRA & CytoDyn Partner to Advance ctDNA-Guided Development in mCRC

Taiwan simulates destroying an invading Chinese force in coastal drill

Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Next reads from the same story arc

Sanofi Wins EU Nod for Subcutaneous Sarclisa in Multiple Myeloma

Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer

What matters in this story

Sentiment in this article

Relationships in this article

You’re reading about it. Someone else is already positioned.

Next reads from the same story arc

Sanofi Wins EU Nod for Subcutaneous Sarclisa in Multiple Myeloma

Analytical profile by cluster

Top impact dimensions

Most positively impacted

Most negatively impacted

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

Pentagon expands list of China military-linked firms to include Alibaba, Baidu in fresh blow to diplomatic thaw

NTRA & CytoDyn Partner to Advance ctDNA-Guided Development in mCRC

Taiwan simulates destroying an invading Chinese force in coastal drill